» Articles » PMID: 23072488

Local Modulation of Cystic Fibrosis Conductance Regulator: Cytoskeleton and Compartmentalized CAMP Signalling

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2012 Oct 18
PMID 23072488
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The cystic fibrosis conductance regulator (CFTR) is a cAMP-regulated Cl(-) channel expressed predominantly at the apical membrane of secreting epithelial cells. Mutations in the CFTR gene lead to cystic fibrosis, the most frequent genetic disease in the Caucasian population. The most common mutation, a deletion of phenylalanine at position 508 (F508del), impairs CFTR folding and chloride channel function. Although an intense effort is under way to identify compounds that target the F508del CFTR structural defect and promote its expression and stability at the plasma membrane, so far their clinical efficacy has proven to be poor, highlighting the necessity to better understand the molecular mechanism of CFTR regulation and of the pathogenesis of the disease. Accumulating evidence suggests that the inclusion of the CFTR in macromolecular complexes and its interaction with the cortical cytoskeleton may play a key role in fine-tuning the regulation of channel function. Here we review some recent findings that support a critical role for protein-protein interactions involving CFTR and for the cytoskeleton in promoting local control of channel activity. These findings indicate that compounds that rescue and stabilize CFTR at the apical membrane may not be sufficient to restore its function unless the appropriate intracellular milieu is also reconstituted.

Citing Articles

A Proteomic Survey of the Cystic Fibrosis Transmembrane Conductance Regulator Surfaceome.

Iazzi M, Sadeghi S, Gupta G Int J Mol Sci. 2023; 24(14).

PMID: 37511222 PMC: 10380767. DOI: 10.3390/ijms241411457.


CFTR, Cell Junctions and the Cytoskeleton.

Pankonien I, Quaresma M, Rodrigues C, Amaral M Int J Mol Sci. 2022; 23(5).

PMID: 35269829 PMC: 8910340. DOI: 10.3390/ijms23052688.


Dysregulation of ion transport in the lung epithelium infected with SARS-CoV-2.

Dada L, Vagin O, Sznajder J Am J Physiol Lung Cell Mol Physiol. 2021; 320(6):L1183-L1185.

PMID: 33881360 PMC: 8238444. DOI: 10.1152/ajplung.00170.2021.


SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport.

Abdel Hameid R, Cormet-Boyaka E, Kuebler W, Uddin M, Berdiev B Am J Physiol Lung Cell Mol Physiol. 2021; 320(3):L430-L435.

PMID: 33434105 PMC: 7938641. DOI: 10.1152/ajplung.00499.2020.


Tobacco Smoke Constituents Trigger Cytoplasmic Calcium Release.

Sassano M, Ghosh A, Tarran R Appl In Vitro Toxicol. 2017; 3(2):193-198.

PMID: 28620626 PMC: 5469188. DOI: 10.1089/aivt.2016.0039.


References
1.
Fievet B, Gautreau A, Roy C, Del Maestro L, Mangeat P, Louvard D . Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol. 2004; 164(5):653-9. PMC: 2172172. DOI: 10.1083/jcb.200307032. View

2.
Proesmans M, Vermeulen F, De Boeck K . What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. Eur J Pediatr. 2008; 167(8):839-49. DOI: 10.1007/s00431-008-0693-2. View

3.
Moyer B, Duhaime M, Shaw C, Denton J, Reynolds D, Karlson K . The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J Biol Chem. 2000; 275(35):27069-74. DOI: 10.1074/jbc.M004951200. View

4.
Prat A, Xiao Y, Ausiello D, Cantiello H . cAMP-independent regulation of CFTR by the actin cytoskeleton. Am J Physiol. 1995; 268(6 Pt 1):C1552-61. DOI: 10.1152/ajpcell.1995.268.6.C1552. View

5.
Sharma M, Benharouga M, Hu W, Lukacs G . Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J Biol Chem. 2001; 276(12):8942-50. DOI: 10.1074/jbc.M009172200. View